https://health.economictimes.indiatimes.com/news/pharma/jj-to-discontinue-hiv-vaccine-trial/97117368
The trial involved administering two different types of a shot, which uses a cold-causing virus to deliver the genetic code of HIV, spread over four vaccination visits in a year. J&J used similar technology for its COVID-19 vaccine. However, The trial's failu…
Create an account or login to join the discussion